BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38664597)

  • 1. Tumour organoids and assembloids: Patient-derived cancer avatars for immunotherapy.
    Mei J; Liu X; Tian HX; Chen Y; Cao Y; Zeng J; Liu YC; Chen Y; Gao Y; Yin JY; Wang PY
    Clin Transl Med; 2024 Apr; 14(4):e1656. PubMed ID: 38664597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor Organoids: The Era of Personalized Medicine.
    Rassomakhina NV; Ryazanova AY; Likhov AR; Bruskin SA; Maloshenok LG; Zherdeva VV
    Biochemistry (Mosc); 2024 Jan; 89(Suppl 1):S127-S147. PubMed ID: 38621748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-Derived Tumor Organoids for Drug Repositioning in Cancer Care: A Promising Approach in the Era of Tailored Treatment.
    Vivarelli S; Candido S; Caruso G; Falzone L; Libra M
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33291603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live Imaging to Quantify Cellular Radiosensitivity in Patient-Derived Tumor Organoids.
    Charpentier M; Bloy N; Formenti SC; Galluzzi L; Demaria S
    J Vis Exp; 2024 Apr; (206):. PubMed ID: 38647326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer.
    Grützmeier SE; Kovacevic B; Vilmann P; Rift CV; Melchior LC; Holmström MO; Brink L; Hassan H; Karstensen JG; Grossjohann H; Chiranth D; Toxværd A; Hansen CP; Høgdall E; Hasselby JP; Klausen P
    Cancers (Basel); 2023 Jul; 15(14):. PubMed ID: 37509338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Cell and Organoid-Level Analysis of Patient-Derived 3D Organoids to Evaluate Tumor Cell Growth Dynamics and Drug Response.
    Kim S; Choung S; Sun RX; Ung N; Hashemi N; Fong EJ; Lau R; Spiller E; Gasho J; Foo J; Mumenthaler SM
    SLAS Discov; 2020 Aug; 25(7):744-754. PubMed ID: 32349587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The TRIPLEX study: use of patient-derived tumor organoids as an innovative tool for precision medicine in triple-negative breast cancer.
    Divoux J; Florent R; Jacobs M; Lequesne J; Grellard JM; San C; Grossi S; Kerdja K; Clarisse B; Boudier G; Cherifi F; Briand M; Dolivet E; Johnson A; Dubois B; Harter V; Lacroix J; Raboutet C; Marie B; Rousseau N; Blanc-Fournier C; Vaur D; Figeac M; Poulain L; Weiswald LB; Emile G
    BMC Cancer; 2023 Sep; 23(1):883. PubMed ID: 37726786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling rectal cancer to advance neoadjuvant precision therapy.
    Janakiraman H; Zhu Y; Becker SA; Wang C; Cross A; Curl E; Lewin D; Hoffman BJ; Warren GW; Hill EG; Timmers C; Findlay VJ; Camp ER
    Int J Cancer; 2020 Sep; 147(5):1405-1418. PubMed ID: 31989583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Culture of patient-derived multicellular clusters in suspended hydrogel capsules for pre-clinical personalized drug screening.
    Dong H; Li Z; Bian S; Song G; Song W; Zhang M; Xie H; Zheng S; Yang X; Li T; Song P
    Bioact Mater; 2022 Dec; 18():164-177. PubMed ID: 35387168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical translation of patient-derived tumour organoids- bottlenecks and strategies.
    Foo MA; You M; Chan SL; Sethi G; Bonney GK; Yong WP; Chow EK; Fong ELS; Wang L; Goh BC
    Biomark Res; 2022 Mar; 10(1):10. PubMed ID: 35272694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging organoid-immune co-culture models for cancer research: from oncoimmunology to personalized immunotherapies.
    Magré L; Verstegen MMA; Buschow S; van der Laan LJW; Peppelenbosch M; Desai J
    J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37220953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer.
    Martini G; Belli V; Napolitano S; Ciaramella V; Ciardiello D; Belli A; Izzo F; Avallone A; Selvaggi F; Menegon Tasselli F; Santaniello W; Franco R; Puig I; Ramirez L; Chicote I; Mancuso F; Caratu G; Serres X; Fasani R; Jimenez J; Ros J; Baraibar I; Mulet N; Della Corte CM; Troiani T; Vivancos A; Dienstmann R; Elez E; Palmer HG; Tabernero J; Martinelli E; Ciardiello F; Argilés G
    ESMO Open; 2023 Jun; 8(3):101198. PubMed ID: 37119788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold.
    Hu LF; Yang X; Lan HR; Fang XL; Chen XY; Jin KT
    Exp Cell Res; 2021 Nov; 408(2):112858. PubMed ID: 34600901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient-Derived Organoids for Precision Cancer Immunotherapy.
    Grönholm M; Feodoroff M; Antignani G; Martins B; Hamdan F; Cerullo V
    Cancer Res; 2021 Jun; 81(12):3149-3155. PubMed ID: 33687948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organoid technology and applications in cancer research.
    Xu H; Lyu X; Yi M; Zhao W; Song Y; Wu K
    J Hematol Oncol; 2018 Sep; 11(1):116. PubMed ID: 30219074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparametric Tumor Organoid Drug Screening Using Widefield Live-Cell Imaging for Bulk and Single-Organoid Analysis.
    Le Compte M; Cardenas De La Hoz E; Peeters S; Smits E; Lardon F; Roeyen G; Vanlanduit S; Prenen H; Peeters M; Lin A; Deben C
    J Vis Exp; 2022 Dec; (190):. PubMed ID: 36622028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling the impact of decidual senescence on embryo implantation in human endometrial assembloids.
    Rawlings TM; Makwana K; Taylor DM; Molè MA; Fishwick KJ; Tryfonos M; Odendaal J; Hawkes A; Zernicka-Goetz M; Hartshorne GM; Brosens JJ; Lucas ES
    Elife; 2021 Sep; 10():. PubMed ID: 34487490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The landscape of drug sensitivity and resistance in sarcoma.
    Al Shihabi A; Tebon PJ; Nguyen HTL; Chantharasamee J; Sartini S; Davarifar A; Jensen AY; Diaz-Infante M; Cox H; Gonzalez AE; Swearingen S; Tavanaie N; Dry S; Singh A; Chmielowski B; Crompton JG; Kalbasi A; Eilber FC; Hornicek F; Bernthal N; Nelson SD; Boutros PC; Federman N; Yanagawa J; Soragni A
    bioRxiv; 2023 Aug; ():. PubMed ID: 37292676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next generation patient derived tumor organoids.
    Podaza E; Kuo HH; Nguyen J; Elemento O; Martin ML
    Transl Res; 2022 Dec; 250():84-97. PubMed ID: 35964899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine.
    Qu S; Xu R; Yi G; Li Z; Zhang H; Qi S; Huang G
    Mol Biomed; 2024 Feb; 5(1):6. PubMed ID: 38342791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.